Dassault Systèmes and Medidata Solutions will lead the Digital Transformation of life sciences in the age of personalized medicine and patient-centric experience.
Dassault Systèmes has acquired Medidata Solutions, whose clinical expertise and cloud-based solutions power the smarter development and commercialization of treatments. The acquisition positions Dassault Systèmes to lead the digital transformation of life sciences in the age of personalized medicine and patient-centric experience through a comprehensive offering that reflects a deep understanding of healthcare, its ecosystem and market needs.
Together with Medidata’s solutions and its great talents that we are delighted to welcome, we bring an unmatched combination of assets to reinforce our vision, science-based culture, and life sciences industry knowledge and know-how. Medidata will be a core brand in our information intelligence domain. By combining data intelligence and simulation, we power smarter therapeutics for healthier people. The inclusive and multi-discipline 3DEXPERIENCE platform will be key for healthcare innovators to anticipate and address the needs of the industry’s transformation toward affordable precision healthcare in the 21st century. The virtual world will push the bounds of possibilities to transform not only research and science, but also the entire pharmaceutical and medical device industry and medicine, in general. We made virtual twins of cars and airplanes possible. We will do the same for the human body”
Bernard Charlès, Vice Chairman and CEO, Dassault Systèmes.
Following the rapid integration of Medidata talent into Dassault Systèmes, Medidata will operate as a Dassault Systèmes brand powered by the 3DEXPERIENCE platform. The life sciences industry will become Dassault Systèmes’ second largest core business after transportation and mobility, advancing sustainable innovation in the biosphere through the intelligent use of biological, chemical and materials science, clinical trials and real-world data on the cloud.